This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Diagnosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Diagnosis of generalized convulsive status epilepticus is usually straightforward with the patient presenting with generalized tonic or clonic activity (1)

The following investigations should be carried out as soon as possible and should accompany pharmacological interventions simultaneously (2).

  • in all patients
    • fingerstick glucose (BM)
    • monitor vital signs
    • computed tomography (CT) scan (appropriate for most cases) of the head- once the patients is stabilised
    • laboratory studies:
      • blood glucose
      • complete blood count
      • basic metabolic panel e.g. - serum electrolytes, blood urea nitrogen (BUN), creatinine,
      • calcium (total and ionized)
      • magnesium
      • AED levels
    • continuous electroencephalograph (EEG) monitoring

  • according to the clinical presentation (patient's history and events leading up to presentation)
    • brain MRI
    • lumbar puncture - in suspected cases of CNS infection or subarachnoid hemorrhage
    • comprehensive toxicology screen to identify toxins which may be responsible for seizures e.g - isoniazid, tricyclic antidepressants, theophylline cocaine, sympathomimetics, alcohol, organophosphates, and cyclosporine
    • other laboratory tests e.g. - liver function tests,

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.